Advices about health like recognising symptoms of allergies, depression, treatment of alcoholism, best medicine for migraines. Everything from healthy food to health insurence.
Pain in lower back
Is an important message that in resolving the acute back pain usual advice - paracetamol and movement - is sufficient for most patients
The best treatment for acute pain in the lower back are common painkiller and normal physical activity, according to a study by Australian researchers. Pomodniji treatments such as spinal manipulation or use of anti-inflammatory drugs, does not help in the recovery, said Mark Hancock and colleagues from the group for the study of pain in the back of the University of Sydney. Most patients who have conducted research recovered within two months of acute back pain without obizra to any additional treatment used. No attempt was related only to acute low back pain, so it is not known whether the same conclusions are true for chronic pain or acute pain from any other part of the body. A team of researchers made the experiment on 240 patients with acute back pain who sought help from general practitioners. Everyone is given the same advice: stay active and drink paracetamol. After that, were randomly divided into four groups of 60 patients, each group received a different type of additional treatment: the first is treated with anti-inflammatory drugs and spinal manipulation by physical therapists, the second also went to the physiotherapist, and she drank a placebo pill, a third was offered fake physiotherapy treatment and anti-inflammatory drug, a fourth group of patients drank the placebo pills and go to the fake physiotherapy treatment. But regardless of the type of treatment, all patients recovered within the same period. Neither anti-inflammatory drugs or physical therapist had no clinically important effect on the shorter recovery. The results are important because they are evaluated both potentially risky treatment, and ancillary costs for patients. The commentary in the journal The Lancet scholar Bart KOES from Erasmus University Medical Center in Rotterdam said that such results could have wider impact.